Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.205
-0.065 (-2.86%)
Sep 3, 2025, 4:00 PM - Market closed
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $106.52 million as of September 3, 2025. Its market cap has decreased by -92.18% in one year.
Market Cap
106.52M
Enterprise Value
-2.72M
1-Year Change
-92.18%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $106.52M, a decrease of -49.89%. That is a compound annual growth rate of -2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 109.66M | -3.42% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | 238.38M | 166.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |